Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

Accessibility StatementSkip Navigation We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts Ademi & Fruchter LLP Guri AdemiToll Free: (866) 264-3995Fax: (414) 482-8001 SOURCE Ademi LLP 21% MILWAUKEE, Nov. 14, 2025 /PRNewswire/ -- The Ademi Firm is investigating Cidara (Nasdaq: CDTX) for possible breaches of fiduciary duty and oth ...